JPS5021469B1 - - Google Patents

Info

Publication number
JPS5021469B1
JPS5021469B1 JP42048203A JP4820367A JPS5021469B1 JP S5021469 B1 JPS5021469 B1 JP S5021469B1 JP 42048203 A JP42048203 A JP 42048203A JP 4820367 A JP4820367 A JP 4820367A JP S5021469 B1 JPS5021469 B1 JP S5021469B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP42048203A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5021469B1 publication Critical patent/JPS5021469B1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP42048203A 1966-07-29 1967-07-28 Pending JPS5021469B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3427566 1966-07-29
GB23066/67A GB1202521A (en) 1966-07-29 1966-07-29 01beta-CHLORO-19-NOR-STEROIDS

Publications (1)

Publication Number Publication Date
JPS5021469B1 true JPS5021469B1 (da) 1975-07-23

Family

ID=26256295

Family Applications (2)

Application Number Title Priority Date Filing Date
JP42048203A Pending JPS5021469B1 (da) 1966-07-29 1967-07-28
JP45075642A Pending JPS5224013B1 (da) 1966-07-29 1970-08-31

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP45075642A Pending JPS5224013B1 (da) 1966-07-29 1970-08-31

Country Status (12)

Country Link
JP (2) JPS5021469B1 (da)
AT (2) AT301766B (da)
BE (1) BE702023A (da)
CH (2) CH580644A5 (da)
DE (1) DE1668124B2 (da)
DK (2) DK129004B (da)
FR (2) FR1565340A (da)
GB (1) GB1202521A (da)
IL (1) IL28411A (da)
NL (1) NL6710459A (da)
PL (1) PL79253B1 (da)
SE (2) SE349025B (da)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5090184A (da) * 1973-12-14 1975-07-19
JPS5090183A (da) * 1973-12-14 1975-07-19

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1289521A (da) * 1969-01-23 1972-09-20
GB1313659A (en) * 1969-07-25 1973-04-18 Glaxo Lab Ltd 9alpha-unsubstituted-11beta-chloro-19-norpregnane compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5090184A (da) * 1973-12-14 1975-07-19
JPS5090183A (da) * 1973-12-14 1975-07-19

Also Published As

Publication number Publication date
NL6710459A (da) 1968-01-30
DK131295C (da) 1975-11-17
PL79253B1 (da) 1975-06-30
GB1202521A (en) 1970-08-19
DK129004B (da) 1974-08-05
FR1565340A (da) 1969-05-02
AT301766B (de) 1972-09-25
JPS5224013B1 (da) 1977-06-28
SE350488B (da) 1972-10-30
IL28411A (en) 1972-07-26
FR7812M (da) 1970-05-20
CH584724A5 (da) 1977-02-15
DK131295B (da) 1975-06-23
AT311564B (de) 1973-11-26
DE1668124B2 (de) 1976-10-07
DE1668124A1 (de) 1971-05-06
SE349025B (da) 1972-09-18
CH580644A5 (da) 1976-10-15
BE702023A (da) 1968-01-29

Similar Documents

Publication Publication Date Title
FR1565340A (da)
AT281852B (da)
AU415165B1 (da)
AU6597365A (da)
BE692307A (da)
BE675139A (da)
BE694053A (da)
BE693936A (da)
BE693750A (da)
BE693660A (da)
BE693654A (da)
BE693633A (da)
BE693093A (da)
BE694439A (da)
BE692664A (da)
BE692446A (da)
BE692436A (da)
BE694494A (da)
BE692113A (da)
BE691209A (da)
BE691008A (da)
BE679570A (da)
BE675084A (da)
BE674987A (da)
BE674882A (da)